Alterity Therapeutics Ltd Stock Australian S.E.
Stocks
AU000000PBT9
OTC Markets Traded
| Market Cap | 75.94M 65.59M 60.44M 56.57M 106M 7.22B 108M 714M 278M 3.51B 285M 279M 12.16B | P/E Ratio 2026 * |
-0.2x | P/E Ratio 2027 * | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 30.75M 26.56M 24.47M 22.91M 42.93M 2.92B 43.6M 289M 113M 1.42B 115M 113M 4.93B | EV / Sales 2026 * |
8.98x | EV / Sales 2027 * | 21.9x |
| Free-Float |
-
| Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alterity Therapeutics Ltd
| 1 day | +2.04% |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 2021-01-06 |
Abby Niven
DFI | Director of Finance/CFO | - | 2024-09-29 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 2005-07-28 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 2011-08-07 |
David Stamler
BRD | Director/Board Member | 65 | 2025-11-20 |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.42M 2.96M 2.73M 2.55M 4.78M 326M 4.86M 32.18M 12.55M 158M 12.85M 12.58M 549M | 1.6M 1.38M 1.27M 1.19M 2.23M 152M 2.27M 15.04M 5.86M 74.04M 6.01M 5.88M 256M |
| Net income | -13.44M -11.61M -10.7M -10.01M -18.77M -1.28B -19.06M -126M -49.25M -622M -50.45M -49.37M -2.15B | -22.29M -19.25M -17.74M -16.61M -31.12M -2.12B -31.6M -209M -81.67M -1.03B -83.65M -81.87M -3.57B |
| Net Debt | -45.19M -39.03M -35.97M -33.67M -63.09M -4.3B -64.07M -425M -166M -2.09B -170M -166M -7.24B | -40.88M -35.31M -32.54M -30.46M -57.08M -3.89B -57.96M -384M -150M -1.89B -153M -150M -6.55B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
